Kolahi Azar H, Gharibshahian M, Rostami M, Mansouri V, Sabouri L, Beheshtizadeh N
J Biol Eng. 2024; 18(1):14.
PMID: 38317174
PMC: 10845631.
DOI: 10.1186/s13036-024-00408-5.
Choi S, Sun A, Cheung J, Ho J
Cancers (Basel). 2024; 16(2).
PMID: 38254743
PMC: 10813668.
DOI: 10.3390/cancers16020252.
Pereira E, de Carvalho M, Nascimento E, Queiroz R, de Almeida A, Antunes A
Asian Pac J Cancer Prev. 2023; 24(9):3087-3097.
PMID: 37774060
PMC: 10762763.
DOI: 10.31557/APJCP.2023.24.9.3087.
Liu H, Wang Z, Zhou Y, Yang Y
Front Immunol. 2023; 14:1199273.
PMID: 37465670
PMC: 10350567.
DOI: 10.3389/fimmu.2023.1199273.
Crozier M, Tubman J, Fifield B, Ferraiuolo R, Ritchie J, Zuccato K
PLoS One. 2022; 17(9):e0274675.
PMID: 36107918
PMC: 9477352.
DOI: 10.1371/journal.pone.0274675.
Gynecologic Cancer, Cancer Stem Cells, and Possible Targeted Therapies.
Keyvani V, Riahi E, Yousefi M, Esmaeili S, Shafabakhsh R, Hasan-Abad A
Front Pharmacol. 2022; 13:823572.
PMID: 35250573
PMC: 8888850.
DOI: 10.3389/fphar.2022.823572.
Templated Three-Dimensional Engineered Bone Matrix as a Model for Breast Cancer Osteolytic Bone Metastasis Process.
Sun M, Huang K, Luo X, Li H
Int J Nanomedicine. 2022; 16:8391-8403.
PMID: 35002234
PMC: 8727640.
DOI: 10.2147/IJN.S338609.
Breast Cancer Derived Extracellular Vesicles in Bone Metastasis Induction and Their Clinical Implications as Biomarkers.
Taverna S, Giusti I, DAscenzo S, Pizzorno L, Dolo V
Int J Mol Sci. 2020; 21(10).
PMID: 32443642
PMC: 7278927.
DOI: 10.3390/ijms21103573.
Chemerin Treatment Inhibits the Growth and Bone Invasion of Breast Cancer Cells.
Kim H, Lee J, Lee S, Song N, Son S, Kim K
Int J Mol Sci. 2020; 21(8).
PMID: 32325994
PMC: 7216174.
DOI: 10.3390/ijms21082871.
The Use of Microfluidic Platforms to Probe the Mechanism of Cancer Cell Extravasation.
Coughlin M, Kamm R
Adv Healthc Mater. 2020; 9(8):e1901410.
PMID: 31994845
PMC: 7274859.
DOI: 10.1002/adhm.201901410.
Elevated Expression of Lumican in Lung Cancer Cells Promotes Bone Metastasis through an Autocrine Regulatory Mechanism.
Hsiao K, Chu P, Chang G, Liu K
Cancers (Basel). 2020; 12(1).
PMID: 31963522
PMC: 7016828.
DOI: 10.3390/cancers12010233.
Development of clinically relevant in vivo metastasis models using human bone discs and breast cancer patient-derived xenografts.
Lefley D, Howard F, Arshad F, Bradbury S, Brown H, Tulotta C
Breast Cancer Res. 2019; 21(1):130.
PMID: 31783893
PMC: 6884811.
DOI: 10.1186/s13058-019-1220-2.
Targeted Nanomedicine to Treat Bone Metastasis.
Adjei I, Temples M, Brown S, Sharma B
Pharmaceutics. 2018; 10(4).
PMID: 30366428
PMC: 6320768.
DOI: 10.3390/pharmaceutics10040205.
17-Estradiol and ICI182,780 Differentially Regulate STAT5 Isoforms in Female Mammary Epithelium, With Distinct Outcomes.
Jallow F, Brockman J, Helzer K, Rugowski D, Goffin V, Alarid E
J Endocr Soc. 2018; 2(3):293-309.
PMID: 29594259
PMC: 5842396.
DOI: 10.1210/js.2017-00399.
Liensinine and Nuciferine, Bioactive Components of , Inhibit the Growth of Breast Cancer Cells and Breast Cancer-Associated Bone Loss.
Kang E, Lee S, Park K, Son S, Kim K, Chung W
Evid Based Complement Alternat Med. 2018; 2017:1583185.
PMID: 29333179
PMC: 5733186.
DOI: 10.1155/2017/1583185.
High uric acid (UA) downregulates bone alkaline phosphatase (BALP) expression through inhibition of its promoter activity.
Wu Z, Chen X, Xu Y, Tian M, Chen H, Zhou G
Oncotarget. 2017; 8(49):85670-85679.
PMID: 29156749
PMC: 5689639.
DOI: 10.18632/oncotarget.21110.
Brucine inhibits bone metastasis of breast cancer cells by suppressing Jagged1/Notch1 signaling pathways.
Hu K, Kong X, Zhong M, Wan H, Lin N, Pei X
Chin J Integr Med. 2016; 23(2):110-116.
PMID: 28035539
DOI: 10.1007/s11655-016-2647-2.
Prognostic Value of Chemotherapy-Induced Neutropenia at the First Cycle in Invasive Breast Cancer.
Ma R, Chen C, Zhang W, You J, Huang D, Guo G
Medicine (Baltimore). 2016; 95(13):e3240.
PMID: 27043697
PMC: 4998558.
DOI: 10.1097/MD.0000000000003240.
The role of macrophages in bone metastasis.
Vasiliadou I, Holen I
J Bone Oncol. 2016; 2(4):158-66.
PMID: 26909287
PMC: 4723381.
DOI: 10.1016/j.jbo.2013.07.002.
Molecular biology of gynecological cancer.
Sonoda K
Oncol Lett. 2016; 11(1):16-22.
PMID: 26834851
PMC: 4727069.
DOI: 10.3892/ol.2015.3862.